Evidence map›Paper›PMID 29172481›Full record

ArticleJournal of agricultural and food chemistry2017

Fucoxanthin and Its Metabolite Fucoxanthinol Do Not Induce Browning in Human Adipocytes.

Candida J Rebello, Frank L Greenway, William D Johnson, David Ribnicky, Alexander Poulev, Krisztian Stadler, Ann A Coulter

Abstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Phytocompounds That Target White Adipose Tissue for Weight Loss: A Review Spanning From Ucp1 Induction in Rodents to Human Clinical Trials.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Candida J RebelloPennington Biomedical Research Center , 6400 Perkins Road, Baton Rouge, Louisiana 70808, United States.
Frank L GreenwayPennington Biomedical Research Center , 6400 Perkins Road, Baton Rouge, Louisiana 70808, United States.ORCID http://orcid.org/0000-0002-1766-6111
William D JohnsonPennington Biomedical Research Center , 6400 Perkins Road, Baton Rouge, Louisiana 70808, United States.
David RibnickyRutgers University 57 US Highway 1, New Brunswick, New Jersey 08901-8554, United States.
Alexander PoulevRutgers University 57 US Highway 1, New Brunswick, New Jersey 08901-8554, United States.
Krisztian StadlerPennington Biomedical Research Center , 6400 Perkins Road, Baton Rouge, Louisiana 70808, United States.
Ann A CoulterPennington Biomedical Research Center , 6400 Perkins Road, Baton Rouge, Louisiana 70808, United States.
Pennington Biomedical Research Center · USRutgers, The State University of New Jersey · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RIBNICKY, DAVID M · 2005 to 2019
$24.9M
Transgenics CoreP30GM118430 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2016 to 2020
$5.8M
Training in Botanical Approaches to Combat Metabolic SyndromeT32AT004094 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BRANTLEY, PHILLIP J, STEPHENS, JACQUELINE M · 2009 to 2024
$5.7M
NCCIH NIH HHS P50 AT002776NCCIH NIH HHS T32 AT004094NIDDK NIH HHS P30 DK072476NIGMS NIH HHS P30 GM118430NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Rodent studies suggest that the antiobesity effects of fucoxanthin relate to activation of brown fat and conversion of white adipocytes to the brown phenotype. To evaluate the browning effect in human adipocytes, we investigated the genes involved in browning and measured the oxygen consumption rate (OCR). Data were analyzed by one way ANOVA. Relative to control, fucoxanthinol (1 μM, 0.1 μM, 0.01 μM, 1 nM, 0.1 nM), the metabolite present in human plasma, stimulated lipolysis acutely (mean ± SEM: 4.2 ± 0.8, 3.1 ± 0.6, 4.1 ± 0.9, 3.8 ± 0.7, 3.8 ± 0.7, respectively, p < 0.01). There was no effect on OCR or the mRNA expression of UCP1, CPT-1β, and GLUT4, the genes associated with browning of adipose tissue, when human adipocytes were treated with fucoxanthin or fucoxanthinol. -mRNA expression of PGC-1α, PPARα, PPARγ, PDK4, FAS, and the lipolytic enzymes was not significantly altered by fucoxanthinol treatment (p > 0.05). Thus, in human adipocytes, fucoxanthin and its metabolite do not stimulate conversion of white adipocytes to the brown phenotype.

Indexed as

AdipocytesAdipose Tissue, Brownbeta CaroteneGlucose Transporter Type 4HumansLipolysisPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR gammaUncoupling Protein 1Xanthophyllsbeta CarotenefucoxanthinfucoxanthinolGlucose Transporter Type 4Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR gammaPPARGC1A protein, humanSLC2A4 protein, humanUCP1 protein, humanUncoupling Protein 1Xanthophyllsadipocytesbrowningfucoxanthinfucoxanthinollipolysis

Identifiers

PMID29172481
PMCPMC5751931
OpenAlexW2770490516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.